{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:44:31Z","timestamp":1775097871310,"version":"3.50.1"},"reference-count":87,"publisher":"Pleiades Publishing Ltd","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1134\/s000629792560019x","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T16:37:05Z","timestamp":1750351025000},"page":"553-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypercellular Proinflammatory Microenvironment Inhibits the Etoposide-Induced DNA Damage in Acute Monocytic Leukemia Cells"],"prefix":"10.1134","volume":"90","author":[{"given":"Margarita I.","family":"Kobyakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill S.","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga V.","family":"Krestinina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia L.","family":"Baburina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly S.","family":"Senotov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana V.","family":"Lomovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena I.","family":"Meshcheriakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey I.","family":"Lomovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena I.","family":"Zvyagina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira V.","family":"Pyatina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina S.","family":"Fadeeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman S.","family":"Fadeev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"2855_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087637","volume":"9","author":"R. Zhang","year":"2014","unstructured":"Zhang, R., Lee, J. Y., Wang, X., Xu, W., Hu, X., Lu, X., Niu, Y., Tang, R., Li, S., and Li, Y. (2014) Identification of novel genomic aberrations in AML-M5 in a level of array CGH, PLoS One, 9, e87637, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0087637.","journal-title":"PLoS One"},{"key":"2855_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.911093","volume":"10","author":"E. Varotto","year":"2022","unstructured":"Varotto, E., Munaretto, E., Stefanachi, F., Della Torre, F., and Buldini, B. (2022) Diagnostic challenges in acute monoblastic\/monocytic leukemia in children, Front. Pediatr., 10, 911093, \nhttps:\/\/doi.org\/10.3389\/fped.2022.911093.","journal-title":"Front. Pediatr."},{"key":"2855_CR3","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1002\/cam4.3023","volume":"9","author":"L. P. Liu","year":"2020","unstructured":"Liu, L. P., Zhang, A. L., Ruan, M., Chang, L. X., Liu, F., Chen, X., Qi, B. Q., Zhang, L., Zou, Y., Chen, Y. M., Chen, X. J., Yang, W. Y., Guo, Y., and Zhu, X. F. (2020) Prognostic stratification of molecularly and clinically distinct subgroup in children with acute monocytic leukemia, Cancer Med., 9, 3647-3655, \nhttps:\/\/doi.org\/10.1002\/cam4.3023.","journal-title":"Cancer Med."},{"key":"2855_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S. Shimony","year":"2023","unstructured":"Shimony, S., Stahl, M., and Stone, R. M. (2023) Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management, Am.\u00a0J. Hematol., 98, 502-526, \nhttps:\/\/doi.org\/10.1002\/ajh.26822.","journal-title":"Am.\u00a0J. Hematol."},{"key":"2855_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33165","volume":"14","author":"E. Y. Arwanih","year":"2022","unstructured":"Arwanih, E. Y., Louisa, M., Rinaldi, I., and Wanandi, S. I. (2022) Resistance mechanism of acute myeloid leukemia cells against daunorubicin and cytarabine: a literature review, Cureus, 14, e33165, \nhttps:\/\/doi.org\/10.7759\/cureus.33165.","journal-title":"Cureus"},{"key":"2855_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ijc.33908","volume":"150","author":"S. Ganesan","year":"2022","unstructured":"Ganesan, S., Mathews, V., and Vyas, N. (2022) Microenvironment and drug resistance in acute myeloid leukemia: do we know enough? Int.\u00a0J. Cancer, 150, 1401-1411, \nhttps:\/\/doi.org\/10.1002\/ijc.33908.","journal-title":"Int.\u00a0J. Cancer"},{"key":"2855_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112833","volume":"10","author":"S. M. Bolandi","year":"2021","unstructured":"Bolandi, S. M., Pakjoo, M., Beigi, P., Kiani, M., Allahgholipour, A., Goudarzi, N., Khorashad, J. S., and Eiring, A. M. (2021) A\u00a0role for the bone marrow microenvironment in drug resistance of acute myeloid leukemia, Cells, 10, 2833, \nhttps:\/\/doi.org\/10.3390\/cells10112833.","journal-title":"Cells"},{"key":"2855_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/JEP.S254334","volume":"12","author":"F. Pourrajab","year":"2020","unstructured":"Pourrajab, F., Zare-Khormizi, M. R., Hekmatimoghaddam, S., and Hashemi, A. S. (2020) Molecular targeting and rational chemotherapy in acute myeloid leukemia, J.\u00a0Exp. Pharmacol., 12, 107-128, \nhttps:\/\/doi.org\/10.2147\/JEP.S254334.","journal-title":"J.\u00a0Exp. Pharmacol."},{"key":"2855_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm503003","volume":"5","author":"J. N. Saultz","year":"2016","unstructured":"Saultz, J. N., and Garzon, R. (2016) Acute myeloid leukemia: a concise review, J.\u00a0Clin. Med., 5, 33, \nhttps:\/\/doi.org\/10.3390\/jcm503003.","journal-title":"J.\u00a0Clin. Med."},{"key":"2855_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101169","volume":"14","author":"W. Zhang","year":"2021","unstructured":"Zhang, W., Gou, P., Dupret, J. M., Chomienne, C., and Rodrigues-Lima, F. (2021) Etoposide, an anticancer drug involved in therapy-related secondary leukemia: enzymes at play, Transl. Oncol.,\u00a014, e101169, \nhttps:\/\/doi.org\/10.1016\/j.tranon.2021.101169.","journal-title":"Transl. Oncol."},{"key":"2855_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000286","volume":"43","author":"S. J. McKie","year":"2021","unstructured":"McKie, S. J., Neuman, K. C., and Maxwell, A. (2021) DNA topoisomerases: Advances in understanding of cellular roles and multi-protein complexes via structure-function analysis, Bioessays, 43, e2000286, \nhttps:\/\/doi.org\/10.1002\/bies.202000286.","journal-title":"Bioessays"},{"key":"2855_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejmech.2019.03.034","volume":"171","author":"X. Liang","year":"2019","unstructured":"Liang, X., Wu, Q., Luan, S., Yin, Z., He, C., Yin, L., Zou, Y., Yuan, Z., Li, L., Song, X., He, M., Lv, C., and Zhang, W. (2019) A\u00a0comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade, Eur.\u00a0J. Med. Chem., 171, 129-168, \nhttps:\/\/doi.org\/10.1016\/j.ejmech.2019.03.034.","journal-title":"Eur.\u00a0J. Med. Chem."},{"key":"2855_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.2910260208","volume":"26","author":"S. Tsuchiya","year":"1980","unstructured":"Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., and Tada, K. (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int.\u00a0J. Cancer, 26, 171-176, \nhttps:\/\/doi.org\/10.1002\/ijc.2910260208.","journal-title":"Int.\u00a0J. Cancer"},{"key":"2855_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01822-w","volume":"10","author":"F. Yu","year":"2024","unstructured":"Yu, F., Chen, Y., Zhou, M., Liu, L., Liu, B., Liu, J., Pan, T., Luo, Y., Zhang, X., Ou, H., Huang, W., Lv, X., Xi, Z., Xiao, R., Li, W., Cao, L., Ma, X., Zhang, J., Lu, L., and Zhang, H. (2024) Generation of a new therapeutic D-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway, Cell Death Discov., 10, 51, \nhttps:\/\/doi.org\/10.1038\/s41420-024-01822-w.","journal-title":"Cell Death Discov."},{"key":"2855_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079106","volume":"8","author":"C. Xie","year":"2013","unstructured":"Xie, C., Drenberg, C., Edwards, H., Caldwell, J. T., Chen, W., Inaba, H., Xu, X., Buck, S. A., Taub, J. W., Baker, S. D., and Ge, Y. (2013) Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51, PLoS One, 8, e79106, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0079106.","journal-title":"PLoS One"},{"key":"2855_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1901-8","volume":"17","author":"B. Giri","year":"2019","unstructured":"Giri, B., Gupta, V. K., Yaffe, B., Modi, S., Roy, P., Sethi, V., Lavania, S. P., Vickers, S. M., Dudeja, V., Banerjee, S., Watts, J., and Saluja, A. (2019) Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia, J.\u00a0Transl. Med., 17, 163, \nhttps:\/\/doi.org\/10.1186\/s12967-019-1901-8.","journal-title":"J.\u00a0Transl. Med."},{"key":"2855_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3892\/or.15.1.207","volume":"15","author":"V. Martino","year":"2006","unstructured":"Martino, V., Tonelli, R., Montemurro, L., Franzoni, M., Marino, F., Fazzina, R., and Pession, A. (2006) Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23),\u00a0Oncol. Rep.,\u00a015, 207-211, \nhttps:\/\/doi.org\/10.3892\/or.15.1.207.","journal-title":"Oncol. Rep."},{"key":"2855_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","volume":"56","author":"M. Umeda","year":"2024","unstructured":"Umeda, M., Ma, J., Westover, T., Ni, Y., Song, G., Maciaszek, J. L., Rusch, M., Rahbarinia, D., Foy, S., Huang, B. J., Walsh, M. P., Kumar, P., Liu, Y., Yang, W., Fan, Y., Wu, G., Baker, S. D., Ma, X., Wang, L., Alonzo, T. A., and Klco, J. M. (2024) A\u00a0new genomic framework to categorize pediatric acute myeloid leukemia, Nat. Genet., 56, 281-293, \nhttps:\/\/doi.org\/10.1038\/s41588-023-01640-3.","journal-title":"Nat. Genet."},{"key":"2855_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.leu.2403236","volume":"18","author":"H. G. Drexler","year":"2004","unstructured":"Drexler, H. G., Quentmeier, H., and MacLeod, R. A. (2004) Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations, Leukemia, 18, 227-232, \nhttps:\/\/doi.org\/10.1038\/sj.leu.2403236.","journal-title":"Leukemia"},{"key":"2855_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284744","volume":"18","author":"J. M. Pang","year":"2023","unstructured":"Pang, J. M., Chien, P. C., Kao, M. C., Chiu, P. Y., Chen, P. X., Hsu, Y. L., Liu, C., Liang, X., and Lin, K. T. (2023) MicroRNA-708 emerges as a potential candidate to target undruggable NRAS, PLoS One, 18, e0284744, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0284744.","journal-title":"PLoS One"},{"key":"2855_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ijc.34019","volume":"151","author":"F. Kasai","year":"2022","unstructured":"Kasai, F., Hirayama, N., Fukushima, M., Kohara, A., and Nakamura, Y. (2022) THP-1 reference data: proposal of an in\u00a0vitro branched evolution model for cancer cell lines, Int.\u00a0J. Cancer, 151, 463-472, \nhttps:\/\/doi.org\/10.1002\/ijc.34019.","journal-title":"Int.\u00a0J. Cancer"},{"key":"2855_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12185-012-1033-x","volume":"95","author":"H. Sano","year":"2012","unstructured":"Sano, H., Shimada, A., Taki, T., Murata, C., Park, M. J., Sotomatsu, M., Tabuchi, K., Tawa, A., Kobayashi, R., Horibe, K., Tsuchida, M., Hanada, R., Tsukimoto, I., and Hayashi, Y. (2012) RAS mutations are frequent in FAB type\u00a0M4 and\u00a0M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study Group, Int.\u00a0J. Hematol., 95, 509-515, \nhttps:\/\/doi.org\/10.1007\/s12185-012-1033-x.","journal-title":"Int.\u00a0J. Hematol."},{"key":"2855_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/gcc.22373","volume":"55","author":"A. C. Laursen","year":"2016","unstructured":"Laursen, A. C., Sandahl, J. D., Kjeldsen, E., Abrahamsson, J., Asdahl, P., Ha, S. Y., Heldrup, J., Jahnukainen, K., J\u00f3nsson, \u00d3. G., Lausen, B., Palle, J., Zeller, B., Forestier, E., and Hasle, H. (2016) Trisomy\u00a08 in pediatric acute myeloid leukemia: A\u00a0NOPHO-AML study, Genes Chromosomes Cancer, 55, 719-726, \nhttps:\/\/doi.org\/10.1002\/gcc.22373.","journal-title":"Genes Chromosomes Cancer"},{"key":"2855_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z","volume":"29","author":"M. D. Odero","year":"2000","unstructured":"Odero, M. D., Zeleznik-Le, N. J., Chinwalla, V., and Rowley, J. D. (2000) Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation, Genes Chromosomes Cancer, 29, 333-338, \nhttps:\/\/doi.org\/10.1002\/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z.","journal-title":"Genes Chromosomes Cancer"},{"key":"2855_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100397","volume":"37","author":"S. Loghavi","year":"2024","unstructured":"Loghavi, S., Kanagal-Shamanna, R., Khoury, J. D., Medeiros, L. J., Naresh, K. N., Nejati, R., Patnaik, M. M., and WHO 5th Edition Classification Project (2024) Fifth Edition of the World Health Classification of tumors of the hematopoietic and lymphoid tissue: myeloid neoplasms, Mod. Pathol., 37, 100397, \nhttps:\/\/doi.org\/10.1016\/j.modpat.2023.100397.","journal-title":"Mod. Pathol."},{"key":"2855_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147881","volume":"23","author":"M. Kobyakova","year":"2022","unstructured":"Kobyakova, M., Lomovskaya, Y., Senotov, A., Lomovsky, A., Minaychev, V., Fadeeva, I., Shtatnova, D., Krasnov, K., Zvyagina, A., Odinokova, I., Akatov, V., and Fadeev, R. (2022) The\u00a0increase in the drug resistance of acute myeloid leukemia THP-1 cells in high-density cell culture is associated with inflammatory-like activation and anti-apoptotic Bcl-2 proteins, Int.\u00a0J. Mol. Sci., 23, 7881, \nhttps:\/\/doi.org\/10.3390\/ijms23147881.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2855_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1134\/S1990747821010050","volume":"15","author":"M. I. Kobyakova","year":"2021","unstructured":"Kobyakova,\u00a0M. I., Evstratova,\u00a0Y. V., Senotov,\u00a0A. S., Lomovsky,\u00a0A. I., Minaichev,\u00a0V. V., Zvyagina,\u00a0A. I., Solovieva,\u00a0M. E., Fadeeva,\u00a0I. S., Akatov,\u00a0V. S., and Fadeev, R. S. (2021) Appearance of signs of differentiation and pro-inflammatory phenotype in acute myeloid leukemia cells THP-1 with an increase in their TRAIL resistance in cell aggregates in\u00a0vitro, Biochemistry (Moscow) Suppl. Ser. Membr. Cell Biol., 15, 97-105, \nhttps:\/\/doi.org\/10.1134\/S1990747821010050.","journal-title":"Biochemistry (Moscow) Suppl. Ser. Membr. Cell Biol."},{"key":"2855_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3426407","volume":"2022","author":"S. Lu","year":"2022","unstructured":"Lu, S., Li, Y., Zhu, C., Wang, W., and Zhou, Y. (2022) Managing cancer drug resistance from the perspective of inflammation, J.\u00a0Oncol, 2022, 3426407, \nhttps:\/\/doi.org\/10.1155\/2022\/3426407.","journal-title":"J.\u00a0Oncol"},{"key":"2855_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/10409238.2013.875514","volume":"49","author":"D. Kidane","year":"2014","unstructured":"Kidane, D., Chae, W. J., Czochor, J., Eckert, K. A., Glazer, P. M., Bothwell, A. L., and Sweasy, J. B. (2014) Interplay between DNA repair and inflammation, and the link to cancer, Crit. Rev. Biochem. Mol. Boil., 49, 116-139, \nhttps:\/\/doi.org\/10.3109\/10409238.2013.875514.","journal-title":"Crit. Rev. Biochem. Mol. Boil."},{"key":"2855_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.mrrev.2014.11.004","volume":"763","author":"F. L. Fontes","year":"2015","unstructured":"Fontes, F. L., Pinheiro, D. M., Oliveira, A. H., Oliveira, R. K., Lajus, T. B., and Agnez-Lima, L. F. (2015) Role of DNA repair in host immune response and inflammation, Mutat. Res. Rev. Mutat. Res., 763, 246-257, \nhttps:\/\/doi.org\/10.1016\/j.mrrev.2014.11.004.","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"2855_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010041","volume":"9","author":"S. Pazzaglia","year":"2019","unstructured":"Pazzaglia, S., and Pioli, C. (2019) Multifaceted role of PARP-1 in DNA repair and inflammation: pathological and therapeutic implications in cancer and non-cancer diseases, Cells, 9, 41, \nhttps:\/\/doi.org\/10.3390\/cells9010041.","journal-title":"Cells"},{"key":"2855_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1134\/S0006297924030040","volume":"89","author":"M. I. Kobyakova","year":"2024","unstructured":"Kobyakova, M. I., Senotov, A. S., Krasnov, K. S., Lomovskaya, Y. V., Odinokova, I. V., Kolotova, A. A., Ermakov, A. M., Zvyagina, A. I., Fadeeva, I. S., Fetisova, E. I., Akatov, V. S., and Fadeev, R. S. (2024) Pro-Inflammatory activation suppresses TRAIL-induced apoptosis of acute myeloid leukemia cells, Biochemistry (Moscow), 89, 431-440, \nhttps:\/\/doi.org\/10.1134\/S0006297924030040.","journal-title":"Biochemistry (Moscow)"},{"key":"2855_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1385\/0-89603-268-X:9","volume":"32","author":"N. J. Kruger","year":"1994","unstructured":"Kruger, N. J. (1994) The\u00a0Bradford method for protein quantitation, Methods Mol. Boil., 32, 9-15, \nhttps:\/\/doi.org\/10.1385\/0-89603-268-X:9.","journal-title":"Methods Mol. Boil."},{"key":"2855_CR34","first-page":"852","volume":"55","author":"Yu. V. Rylova","year":"2013","unstructured":"Rylova, Yu. V., and Buravkova, L. B. (2013) Long-term expansion of multipotent mesenchymal stromal cells under reduced oxygen tension, Tsitologiya, 55, 852-860.","journal-title":"Tsitologiya"},{"key":"2855_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.32607\/actanaturae.27317","volume":"16","author":"Y. V. Lomovskaya","year":"2024","unstructured":"Lomovskaya, Y. V., Krasnov, K. S., Kobyakova, M. I., Kolotova, A. A., Ermakov, A. M., Senotov, A. S., Fadeeva, I. S., Fetisova, E. I., Lomovsky, A. I., Zvyagina, A. I., Akatov, V. S., and Fadeev, R. S. (2024) Studying signaling pathway activation in TRAIL-resistant macrophage-like acute myeloid leukemia cells, Acta Naturae, 16, 48-58, \nhttps:\/\/doi.org\/10.32607\/actanaturae.27317.","journal-title":"Acta Naturae"},{"key":"2855_CR36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D. Bottomly","year":"2022","unstructured":"Bottomly, D., Long, N., Schultz, A. R., Kurtz, S. E., Tognon, C. E., Johnson, K., Abel, M., Agarwal, A., Avaylon, S., Benton, E., Blucher, A., Borate, U., Braun, T.\u00a0P., Brown, J., Bryant, J., Burke, R., Carlos, A., Chang, B.\u00a0H., Cho, H. J., Christy, S., Coblentz, C., Cohen, A.\u00a0M., d'Almeida, A., Cook, R., Danilov, A., Dao, K.\u00a0T., Degnin, M., Dibb, J., Eide, C.\u00a0A., English, I., Hagler, S., Harrelson, H., Henson, R., Ho, H., Joshi, S.\u00a0K., Junio, B., Kaempf, A., Kosaka, Y., Laderas, T., Lawhead, M., Lee, H., Leonard, J.\u00a0T., Lin, C., Lind, E.\u00a0F., Liu, S.\u00a0Q., Lo, P., Loriaux, M.\u00a0M., Luty, S., Maxson, J.\u00a0E., Macey, T., Martinez, J., Minnier, J., Monteblanco, A., Mori, M., Morrow, Q., Nelson, D., Ramsdill, J., Rofelty, A., Rogers, A., Romine, K. A., Ryabinin, P., Saultz, J. N., Sampson, D.\u00a0A., Savage, S. L., Schuff, R., Searles, R., Smith, R. L., Spurgeon, S. E., Sweeney, T., Swords, R. T., Thapa, A., Thiel-Klare, K., Traer, E., Wagner, J., Wilmot, B., Wolf, J., Wu, G., Yates, A., Zhang, H., Cogle, C. R., Collins, R. H., Deininger, M. W., Hourigan, C. S., Jordan, C. T., Lin, T. L., Martinez, M. E., Pallapati, R. R., Pollyea, D. A., Pomicter, A. D., Watts, J. M., Weir, S. J., Druker, B. J., McWeeney, S. K., and Tyner, J. W. (2022) Integrative analysis of drug response and clinical outcome in acute myeloid leukemia, Cancer Cell, 40, 850-864.e9, \nhttps:\/\/doi.org\/10.1016\/j.ccell.2022.07.002.","journal-title":"Cancer Cell"},{"key":"2855_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y. Benjamini","year":"1995","unstructured":"Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing, J.\u00a0R. Statist. Soc., 57, 289-300, \nhttps:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J.\u00a0R. Statist. Soc."},{"key":"2855_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.629266","volume":"11","author":"L. Y. Li","year":"2021","unstructured":"Li, L. Y., Guan, Y. D., Chen, X. S., Yang, J. M., and Cheng, Y. (2021) DNA repair pathways in cancer therapy and resistance, Front. Pharmacol, 11, 629266, \nhttps:\/\/doi.org\/10.3389\/fphar.2020.629266.","journal-title":"Front. Pharmacol"},{"key":"2855_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314672","volume":"23","author":"D. Jurkovicova","year":"2022","unstructured":"Jurkovicova, D., Neophytou, C. M., Ga\u0161parovi\u0107, A. \u010c., and Gon\u00e7alves, A. C. (2022) DNA damage response in cancer therapy and resistance: challenges and opportunities, Int.\u00a0J. Mol. Sci., 23, 14672, \nhttps:\/\/doi.org\/10.3390\/ijms232314672.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2855_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207504","volume":"21","author":"C. Nastasi","year":"2020","unstructured":"Nastasi, C., Mannarino, L., and D'Incalci, M. (2020) DNA damage response and immune defense, Int.\u00a0J. Mol. Sci., 21, 7504, \nhttps:\/\/doi.org\/10.3390\/ijms21207504.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2855_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1039\/C6MD00439C","volume":"8","author":"C. Ronco","year":"2016","unstructured":"Ronco, C., Martin, A. R., Demange, L., and Benhida, R. (2016) ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells, Medchemcomm., 8, 295-319, \nhttps:\/\/doi.org\/10.1039\/C6MD00439C.","journal-title":"Medchemcomm."},{"key":"2855_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/biom6010002","volume":"6","author":"E. L. Ryan","year":"2016","unstructured":"Ryan, E. L., Hollingworth, R., and Grand, R. J. (2016) Activation of the DNA damage response by RNA viruses, Biomolecul., 6, 2, \nhttps:\/\/doi.org\/10.3390\/biom6010002.","journal-title":"Biomolecul."},{"key":"2855_CR43","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1124\/mol.109.054999","volume":"76","author":"T. W. Day","year":"2009","unstructured":"Day, T. W., Wu, C. H., and Safa, A. R. (2009) Etoposide induces protein kinase Cdelta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells, Mol. Pharmacol., 76, 632-640, \nhttps:\/\/doi.org\/10.1124\/mol.109.054999.","journal-title":"Mol. Pharmacol."},{"key":"2855_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S. Elmore","year":"2007","unstructured":"Elmore, S. (2007) Apoptosis: a review of programmed cell death, Toxicol. Pathol., 35, 495-516, \nhttps:\/\/doi.org\/10.1080\/01926230701320337.","journal-title":"Toxicol. Pathol."},{"key":"2855_CR45","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1128\/mcb.19.7.5124","volume":"19","author":"Z. Herceg","year":"1999","unstructured":"Herceg, Z., and Wang, Z. Q. (1999) Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis, Mol. Cell. Boil., 19, 5124-5133, \nhttps:\/\/doi.org\/10.1128\/mcb.19.7.5124.","journal-title":"Mol. Cell. Boil."},{"key":"2855_CR46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1083\/jcb.126.4.827","volume":"126","author":"F. A. Oberhammer","year":"1994","unstructured":"Oberhammer, F. A., Hochegger, K., Fr\u00f6schl, G., Tiefenbacher, R., and Pavelka, M. (1994) Chromatin condensation during apoptosis is accompanied by degradation of lamin A\u00a0+\u00a0B, without enhanced activation of cdc2 kinase, J.\u00a0Cell Boil., 126, 827-837, \nhttps:\/\/doi.org\/10.1083\/jcb.126.4.827.","journal-title":"J.\u00a0Cell Boil."},{"key":"2855_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109264","volume":"35","author":"S. Bae","year":"2021","unstructured":"Bae, S., Park, P. S. U., Lee, Y., Mun, S. H., Giannopoulou, E., Fujii, T., Lee, K. P., Violante, S. N., Cross, J. R., and Park-Min, K. H. (2021) MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages, Cell Rep., 35, 109264, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2021.109264.","journal-title":"Cell Rep."},{"key":"2855_CR48","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1073\/pnas.1518000113","volume":"113","author":"L. Liu","year":"2016","unstructured":"Liu, L., Lu, Y., Martinez, J., Bi, Y., Lian, G., Wang, T., Milasta, S., Wang, J., Yang, M., Liu, G., Green, D. R., and Wang, R. (2016) Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1\u03b1-dependent, Proc. Natl. Acad. Sci. USA, 113, 1564-1569, \nhttps:\/\/doi.org\/10.1073\/pnas.1518000113.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2855_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/1541-7786.MCR-18-0630","volume":"17","author":"H. Y. Lee","year":"2019","unstructured":"Lee, H. Y., Cha, J., Kim, S. K., Park, J. H., Song, K. H., Kim, P., and Kim, M. Y. (2019) c-MYC drives breast cancer metastasis to the brain, but promotes synthetic lethality with TRAIL, Mol. Cancer Res., 17, 544-554, \nhttps:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0630.","journal-title":"Mol. Cancer Res."},{"key":"2855_CR50","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1080\/14756366.2020.1821676","volume":"35","author":"K. Buzun","year":"2020","unstructured":"Buzun, K., Bielawska, A., Bielawski, K., and Gornowicz, A. (2020) DNA topoisomerases as molecular targets for anticancer drugs, J.\u00a0Enzyme Inhib. Med. Chem., 35, 1781-1799, \nhttps:\/\/doi.org\/10.1080\/14756366.2020.1821676.","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"2855_CR51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-801591-9.00002-3","volume":"2015","author":"C. H. Grant","year":"2015","unstructured":"Grant, C. H., and Gourley, C. (2015) Relevant cancer diagnoses, commonly used chemotherapy agents and their biochemical mechanisms of action, Cancer Treat. Ovary, 2015, 21-33, \nhttps:\/\/doi.org\/10.1016\/B978-0-12-801591-9.00002-3.","journal-title":"Cancer Treat. Ovary"},{"key":"2855_CR52","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.biopha.2018.03.123","volume":"102","author":"S. Jayashree","year":"2018","unstructured":"Jayashree, S., Nirekshana, K., Guha, G., and Bhakta-Guha, D. (2018) Cancer chemotherapeutics in rheumatoid arthritis: a convoluted connection, Biomed. Pharmacother., 102, 894-911, \nhttps:\/\/doi.org\/10.1016\/j.biopha.2018.03.123.","journal-title":"Biomed. Pharmacother."},{"key":"2855_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2018.11.018","volume":"115","author":"J. Lei","year":"2019","unstructured":"Lei, J., Yin, X., Shang, H., and Jiang, Y. (2019) IP-10 is highly involved in HIV infection, Cytokine, 115, 97-103, \nhttps:\/\/doi.org\/10.1016\/j.cyto.2018.11.018.","journal-title":"Cytokine"},{"key":"2855_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S1097-2765(00)80387-1","volume":"4","author":"A. C. Phillips","year":"1999","unstructured":"Phillips, A. C., Ernst, M. K., Bates, S., Rice, N. R., and Vousden, K. H. (1999) E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways, Mol. Cell, 4, 771-781, \nhttps:\/\/doi.org\/10.1016\/S1097-2765(00)80387-1.","journal-title":"Mol. Cell"},{"key":"2855_CR55","doi-asserted-by":"publisher","first-page":"8748","DOI":"10.1158\/0008-5472.CAN-10-0944","volume":"70","author":"K. R. Luoto","year":"2010","unstructured":"Luoto, K. R., Meng, A. X., Wasylishen, A. R., Zhao, H., Coackley, C. L., Penn, L. Z., and Bristow, R. G. (2010) Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair, Cancer Res., 70, 8748-8759, \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0944.","journal-title":"Cancer Res."},{"key":"2855_CR56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G. Bretones","year":"2015","unstructured":"Bretones, G., Delgado, M. D., and Le\u00f3n, J. (2015) Myc and cell cycle control, Biochim. Biophys. Acta, 1849, 506-516, \nhttps:\/\/doi.org\/10.1016\/j.bbagrm.2014.03.013.","journal-title":"Biochim. Biophys. Acta"},{"key":"2855_CR57","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1182\/blood.v80.5.1307.1307","volume":"80","author":"M. Chiron","year":"1992","unstructured":"Chiron, M., Demur, C., Pierson, V., Jaffrezou, J. P., Muller, C., Saivin, S., Bordier, C., Bousquet, C., Dastugue, N., and Laurent, G. (1992)\u00a0Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA single-strand breaks, Blood, 80, 1307-1315,\u00a0\nhttps:\/\/doi.org\/10.1182\/blood.v80.5.1307.1307.","journal-title":"Blood"},{"key":"2855_CR58","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1074\/jbc.M212056200","volume":"278","author":"K. D. Bromberg","year":"2003","unstructured":"Bromberg, K. D., Burgin, A. B., and Osheroff, N. (2003) A\u00a0two-drug model for etoposide action against human topoisomerase IIalpha, J.\u00a0Boil. Chem., 278, 7406-7412, \nhttps:\/\/doi.org\/10.1074\/jbc.M212056200.","journal-title":"J.\u00a0Boil. Chem."},{"key":"2855_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005859","volume":"4","author":"A. Muslimovi\u0107","year":"2009","unstructured":"Muslimovi\u0107, A., Nystr\u00f6m, S., Gao, Y., and Hammarsten, O. (2009) Numerical analysis of etoposide induced DNA breaks, PLoS One, 4, e5859, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0005859.","journal-title":"PLoS One"},{"key":"2855_CR60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/379225a0","volume":"379","author":"J. M. Berger","year":"1996","unstructured":"Berger, J. M., Gamblin, S. J., Harrison, S. C., and Wang, J. C. (1996) Structure and mechanism of DNA topoisomerase\u00a0II, Nature, 379, 225-232, \nhttps:\/\/doi.org\/10.1038\/379225a0.","journal-title":"Nature"},{"key":"2855_CR61","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1054\/bjoc.2001.1786","volume":"84","author":"O. Tounekti","year":"2001","unstructured":"Tounekti, O., Kenani, A., Foray, N., Orlowski, S., and Mir, L. M. (2001) The\u00a0ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway, Br.\u00a0J. Cancer, 84, 1272-1279, \nhttps:\/\/doi.org\/10.1054\/bjoc.2001.1786.","journal-title":"Br.\u00a0J. Cancer"},{"key":"2855_CR62","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1126\/science.1108297","volume":"308","author":"J. H. Lee","year":"2005","unstructured":"Lee, J. H., and Paull, T. T. (2005) ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex, Science, 308, 551-554, \nhttps:\/\/doi.org\/10.1126\/science.1108297.","journal-title":"Science"},{"key":"2855_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/genes12091370","volume":"12","author":"A. Shibata","year":"2021","unstructured":"Shibata, A., and Jeggo, P. A. (2021) ATM's role in the repair of DNA double-strand breaks, Genes, 12, 1370, \nhttps:\/\/doi.org\/10.3390\/genes12091370.","journal-title":"Genes"},{"key":"2855_CR64","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A. Mar\u00e9chal","year":"2013","unstructured":"Mar\u00e9chal, A., and Zou, L. (2013) DNA damage sensing by the ATM and ATR kinases, Cold Spring Harb. Perspect. Boil., 5, a012716, \nhttps:\/\/doi.org\/10.1101\/cshperspect.a012716.","journal-title":"Cold Spring Harb. Perspect. Boil."},{"key":"2855_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00089","volume":"4","author":"R. N. Ganapathi","year":"2013","unstructured":"Ganapathi, R. N., and Ganapathi, M. K. (2013) Mechanisms regulating resistance to inhibitors of topoisomerase\u00a0II, Front. Pharmacol., 4, 89, \nhttps:\/\/doi.org\/10.3389\/fphar.2013.00089.","journal-title":"Front. Pharmacol."},{"key":"2855_CR66","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1021\/bi00356a060","volume":"25","author":"D. M. Sullivan","year":"1986","unstructured":"Sullivan, D. M., Glisson, B. S., Hodges, P. K., Smallwood-Kentro, S., and Ross, W. E. (1986) Proliferation dependence of topoisomerase\u00a0II mediated drug action, Biochem., 25, 2248-2256, \nhttps:\/\/doi.org\/10.1021\/bi00356a060.","journal-title":"Biochem."},{"key":"2855_CR67","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-4781(98)00141-9","volume":"1400","author":"A. M. Dingemans","year":"1998","unstructured":"Dingemans, A. M., Pinedo, H. M., and Giaccone, G. (1998) Clinical resistance to topoisomerase-targeted drugs, Biochim. Biophys. Acta, 1400, 275-288, \nhttps:\/\/doi.org\/10.1016\/S0167-4781(98)00141-9.","journal-title":"Biochim. Biophys. Acta"},{"key":"2855_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-1-4615-5873-6_22","volume":"2","author":"A. K. Larsen","year":"1996","unstructured":"Larsen, A. K., Skladanowski, A., and Bojanowski, K. (1996) The\u00a0roles of DNA topoisomerase\u00a0II during the cell cycle, Prog. Cell Cycle Res., 2, 229-239, \nhttps:\/\/doi.org\/10.1007\/978-1-4615-5873-6_22.","journal-title":"Prog. Cell Cycle Res."},{"key":"2855_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/genes10110859","volume":"10","author":"J. H. Lee","year":"2019","unstructured":"Lee, J. H., and Berger, J. M. (2019) Cell cycle-dependent control and roles of DNA topoisomerase\u00a0II, Genes, 10, 859, \nhttps:\/\/doi.org\/10.3390\/genes10110859.","journal-title":"Genes"},{"key":"2855_CR70","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0021-9258(17)42238-1","volume":"269","author":"K. Kimura","year":"1994","unstructured":"Kimura, K., Saijo, M., Ui, M., and Enomoto, T. (1994) Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase\u00a0II and possible specific modification of the higher molecular weight form in the M\u00a0phase, J.\u00a0Boil. Chem, 269, 1173-1176, \nhttps:\/\/doi.org\/10.1016\/S0021-9258(17)42238-1.","journal-title":"J.\u00a0Boil. Chem"},{"key":"2855_CR71","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.plantsci.2015.09.016","volume":"240","author":"B. N. Singh","year":"2015","unstructured":"Singh, B. N., Mudgil, Y., John, R., Achary, V. M., Tripathy, M. K., Sopory, S. K., Reddy, M. K., and Kaul, T. (2015) Cell cycle stage-specific differential expression of topoisomerase\u00a0I in tobacco BY-2\u00a0cells and its ectopic overexpression and knockdown unravels its crucial role in plant morphogenesis and development, Plant Sci., 240, 182-192, \nhttps:\/\/doi.org\/10.1016\/j.plantsci.2015.09.016.","journal-title":"Plant Sci."},{"key":"2855_CR72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molcel.2021.11.016","volume":"82","author":"S. K. Das","year":"2022","unstructured":"Das, S. K., Kuzin, V., Cameron, D. P., Sanford, S., Jha, R. K., Nie, Z., Rosello, M. T., Holewinski, R., Andresson, T., Wisniewski, J., Natsume, T., Price, D. H., Lewis, B. A., Kouzine, F., Levens, D., and Baranello, L. (2022) MYC assembles and stimulates topoisomerases\u00a01 and\u00a02 in a \u201ctopoisome\u201d, Mol. Cell, 82, 140-158.e12, \nhttps:\/\/doi.org\/10.1016\/j.molcel.2021.11.016.","journal-title":"Mol. Cell"},{"key":"2855_CR73","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1158\/0008-5472.CAN-04-3999","volume":"65","author":"W. Jiao","year":"2005","unstructured":"Jiao, W., Lin, H. M., Timmons, J., Nagaich, A. K., Ng, S. W., Misteli, T., and Rane, S. G. (2005) E2F-dependent repression of topoisomerase\u00a0II regulates heterochromatin formation and apoptosis in cells with melanoma-prone mutation, Cancer Res., 65, 4067-4077, \nhttps:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3999.","journal-title":"Cancer Res."},{"key":"2855_CR74","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1089\/jir.2012.0110","volume":"33","author":"K. P. Kotredes","year":"2013","unstructured":"Kotredes, K. P., and Gamero, A. M. (2013) Interferons as inducers of apoptosis in malignant cells, J.\u00a0Interferon Cytokine Res., 33, 162-170, \nhttps:\/\/doi.org\/10.1089\/jir.2012.0110.","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"2855_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","volume":"9","author":"H. Cheon","year":"2023","unstructured":"Cheon, H., Wang, Y., Wightman, S. M., Jackson, M. W., and Stark, G. R. (2023) How cancer cells make and respond to interferon-I, Trends Cancer, 9, 83-92, \nhttps:\/\/doi.org\/10.1016\/j.trecan.2022.09.003.","journal-title":"Trends Cancer"},{"key":"2855_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00878","volume":"8","author":"S. Di Franco","year":"2017","unstructured":"Di Franco, S., Turdo, A., Todaro, M., and Stassi, G. (2017) Role of type\u00a0I and ii interferons in colorectal cancer and melanoma, Front. Immune., 8, 878, \nhttps:\/\/doi.org\/10.3389\/fimmu.2017.00878.","journal-title":"Front. Immune."},{"key":"2855_CR77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112258118","volume":"118","author":"H. Cheon","year":"2021","unstructured":"Cheon, H., Holvey-Bates, E. G., McGrail, D. J., and Stark, G. R. (2021) PD-L1 sustains chronic, cancer cell-intrinsic responses to type\u00a0I interferon, enhancing resistance to DNA damage, Proc. Natl. Acad. Sci. USA, 118, e2112258118, \nhttps:\/\/doi.org\/10.1073\/pnas.2112258118.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2855_CR78","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1101\/gad.289769.116","volume":"31","author":"E. Erdal","year":"2017","unstructured":"Erdal, E., Haider, S., Rehwinkel, J., Harris, A. L., and McHugh, P. J. (2017) A\u00a0prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1, Genes Dev., 31, 353-369, \nhttps:\/\/doi.org\/10.1101\/gad.289769.116.","journal-title":"Genes Dev."},{"key":"2855_CR79","doi-asserted-by":"publisher","first-page":"77205","DOI":"10.18632\/oncotarget.12858","volume":"7","author":"J. Gaston","year":"2016","unstructured":"Gaston, J., Cheradame, L., Yvonnet, V., Deas, O., Poupon, M. F., Judde, J. G., Cairo, S., and Goffin, V. (2016) Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents, Oncotarget, 7, 77205-77224, \nhttps:\/\/doi.org\/10.18632\/oncotarget.12858.","journal-title":"Oncotarget"},{"key":"2855_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00120","volume":"3","author":"P. Godwin","year":"2013","unstructured":"Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O'Byrne, K. J., and Gately, K. (2013) Targeting nuclear factor-kappa\u00a0B to overcome resistance to chemotherapy, Front. Oncol., 3, 120, \nhttps:\/\/doi.org\/10.3389\/fonc.2013.00120.","journal-title":"Front. Oncol."},{"key":"2855_CR81","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/jir.2011.0028","volume":"31","author":"L. M. Pfeffer","year":"2011","unstructured":"Pfeffer, L. M. (2011) The\u00a0role of nuclear factor \u03baB in the interferon response, J.\u00a0Interferon Cytokine Res., 31, 553-559, \nhttps:\/\/doi.org\/10.1089\/jir.2011.0028.","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"2855_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109977","volume":"37","author":"J. Willemsen","year":"2021","unstructured":"Willemsen, J., Neuhoff, M. T., Hoyler, T., Noir, E., Tessier, C., Sarret, S., Thorsen, T. N., Littlewood-Evans, A., Zhang, J., Hasan, M., Rush, J. S., Guerini, D., and Siegel, R. M. (2021) TNF leads to mtDNA release and cGAS\/STING-dependent interferon responses that support inflammatory arthritis, Cell Rep., 37, 109977, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2021.109977.","journal-title":"Cell Rep."},{"key":"2855_CR83","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","volume":"102","author":"Y. Wu","year":"2010","unstructured":"Wu, Y., and Zhou, B. P. (2010) TNF-alpha\/NF-kappaB\/Snail pathway in cancer cell migration and invasion, British\u00a0J. Cancer, 102, 639-644, \nhttps:\/\/doi.org\/10.1038\/sj.bjc.6605530.","journal-title":"British\u00a0J. Cancer"},{"key":"2855_CR84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0898-6568(00)00149-2","volume":"13","author":"M. Guha","year":"2001","unstructured":"Guha, M., and Mackman, N. (2001) LPS induction of gene expression in human monocytes, Cell. Signal., 13, 85-94, \nhttps:\/\/doi.org\/10.1016\/S0898-6568(00)00149-2.","journal-title":"Cell. Signal."},{"key":"2855_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13880-5","volume":"7","author":"V. Garc\u00eda-Gonz\u00e1lez","year":"2017","unstructured":"Garc\u00eda-Gonz\u00e1lez, V., and Mas-Oliva, J. A. (2017) Novel \u03b2-adaptin\/c-Myc complex formation modulated by oxidative stress in the control of the cell cycle in macrophages and its implication in atherogenesis, Sci. Rep., 7, 13442, \nhttps:\/\/doi.org\/10.1038\/s41598-017-13880-5.","journal-title":"Sci. Rep."},{"key":"2855_CR86","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10473","volume":"5","author":"J. M. Ankers","year":"2016","unstructured":"Ankers, J. M., Awais, R., Jones, N. A., Boyd, J., Ryan, S., Adamson, A. D., Harper, C. V., Bridge, L., Spiller, D. G., Jackson, D. A., Paszek, P., S\u00e9e, V., and White, M. R. (2016) Dynamic NF-\u03baB and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation, eLife, 5, e10473, \nhttps:\/\/doi.org\/10.7554\/eLife.10473.","journal-title":"eLife"},{"key":"2855_CR87","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1038\/onc.2008.184","volume":"27","author":"K. Araki","year":"2008","unstructured":"Araki, K., Kawauchi, K., and Tanaka, N. (2008) IKK\/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors, Oncogene, 27, 5696-5705, \nhttps:\/\/doi.org\/10.1038\/onc.2008.184.","journal-title":"Oncogene"}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S000629792560019X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S000629792560019X","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S000629792560019X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:24:59Z","timestamp":1773620699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S000629792560019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2855"],"URL":"https:\/\/doi.org\/10.1134\/s000629792560019x","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}